Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 1431-1440 of 9367

Page
per page
  1. ML216
    B8015 ML216
    Target: BLM
    Summary: BLM helicase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥10.65 mg/mL
  2. UNC2025
    B8016 UNC2025
     1 Citation
    Target: MER|FLT3
    Summary: orally bioavailable dual MER/FLT3 inhibitor
      ≥23.85 mg/mL
  3. PF 1022A
    B8018 PF 1022A
    Summary: Anthelmintically active cyclodepsipeptide
      ≥31.75 mg/mL
  4. Pimavanserin
    B8019 Pimavanserin
    Summary: 5-HT2A inverse agonist
      ≥21.38 mg/mL
  5. GS-7340
    B8021 GS-7340
    Summary: HIV reverse transcriptase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥16.7 mg/mL
  6. Cerdulatinib (PRT062070)
    B8023 Cerdulatinib (PRT062070)
    Target: JAK|Syk|TYK2
    Summary: Syk/JAK inhibitor
      ≥22.3 mg/mL
  7. ARN2966
    B8029 ARN2966
    Summary: APP expression modulator
      Soluble in DMSO
  8. Myelin Basic Protein (87-99)
    A1040 Myelin Basic Protein (87-99)
    Summary: Encephalitogenic peptide
  9. TCS 3035
    B7783 TCS 3035
    Summary: GPR35 agonist
      <27.93 mg/mL
  10. AL 8697
    B7784 AL 8697
    Target: p38
    Summary: p38α inhibitor,potent and selective
      <40.24 mg/mL

Items 1431-1440 of 9367

Page
per page